Oxygenta Pharmaceutical Limited

As of June 30, 2026, Oxygenta Pharmaceutical Limited carries a market capitalization of 1.79B, placing it among publicly traded companies globally. Its enterprise value stands at 1.79B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of June 30, 2026, Oxygenta Pharmaceutical Limited has 36.98M shares outstanding.

These figures are as of June 30, 2026.

These figures are as of June 30, 2026. The EV/Sales ratio of 1.33 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. These enterprise value multiples are built on an enterprise value of 1.79B versus a market cap of 1.79B, with the gap driven by net debt and cash on the balance sheet.

These figures are as of June 30, 2026.

These figures cover the twelve months ended June 30, 2026. The company generates approximately 7.82M in revenue per employee across its workforce of 172.50, a quick read on workforce productivity versus industry peers.

Over the twelve months ended June 30, 2026, Oxygenta Pharmaceutical Limited recorded an income tax benefit of -29.70M rather than an expense, typically from losses, carryforwards, or the release of a tax provision. The company reported a pretax loss of -165.51M and -135.81M in bottom-line net income, so the effective tax rate carries little signal until profitability returns.

As of the close on October 22, 2026, Oxygenta Pharmaceutical Limited's stock has declined approximately 23.40% over the past 52 weeks. The 50-day moving average sits at 54.36, while the 200-day moving average is 52.90.

Over the twelve months ended June 30, 2026, Oxygenta Pharmaceutical Limited generated 1.35B in revenue and converted that into -135.81M in net income, yielding earnings per share of -3.66. EBITDA reached -79.90M, while operating income came in at -100.84M.

Over the twelve months ended June 30, 2026, Oxygenta Pharmaceutical Limited posted a gross margin of 7.31, reflecting its pricing power and cost economics. The operating margin of -7.48 and net profit margin of -10.07 provide insight into operational efficiency.